首页> 外文期刊>Arabian Journal for Science and Engineering >Development and Characterization of Novel Bigel‑Based 1,4‑Naphthoquinones for Topical Application with Antioxidant Potential
【24h】

Development and Characterization of Novel Bigel‑Based 1,4‑Naphthoquinones for Topical Application with Antioxidant Potential

机译:新型基于Bigel的1,4-萘醌的开发和表征,具有抗氧化潜力

获取原文
获取原文并翻译 | 示例
       

摘要

Discovering new antioxidant agents and optimizing their processing is a necessity to treat skin diseases. The assessment ofquality and antioxidant activity of topical formulations based on 5,8-dihydroxy-1,4-naphthoquinone (M1) and 2,3-dichloro-5,8-dihydroxy-1,4-naphthoquinone (M2) was carried out for the first time for this purpose. Stability studies including evaluationof pH, viscosity, microscopic observation, and microbiological quality were determined. M1 and M2 were examinedfor their antioxidant capacities after their incorporation into bigels. Obtained data suggested that BG-M1 and BG-M2 have agood quality, a natural pH of the skin (4.5–6.0), and no sign of microbial development. Sensory analysis was also performed,and no negative assessment of unpleasant bigel properties was found. M1 and M2 have shown antioxidant activity towardDPPH radical (data are expressed as IC_(50)),19 × 10~(−3) mg/mL for M1 and 35 × 10~(−3) mg/mL for M2, respectively. After theirformulations, they have maintained this ability, for BG-M1 = 3.0 and BG-M2 = 1.1 mg/mL. Also, they demonstrated interestingABTS scavenging with 1.5 × 10~(−3) and 2.5 × 10~(−3) mg/mL for M1 and M2, respectively. They kept this potential afterformulation, since, BG-M1 = 1.7 mg/mL and BG-M2 = 4.9 mg/mL. Likewise, pure molecules revealed notable β-carotenebleaching inhibition (0.3 and 0.1 mg/mL for M1 and M2, respectively), which was maintained after their formulation intobigels (2.9 and 10.3 mg/mL for BG-M1 and BG-M2, respectively). These developed bigels maintaining the antioxidantpotential of M1 and M2 could be used as the provision of a barrier to protect skin.
机译:发现新的抗氧化剂并优化其加工工艺是治疗皮肤疾病的必要条件。对基于5,8-二羟基-1,4-萘醌(M1)和2,3-二氯-5,8-二羟基-1,4-萘醌(M2)的局部制剂的质量和抗氧化活性进行评估第一次为此目的。确定了包括pH值,粘度,显微镜观察和微生物质量评估在内的稳定性研究。将M1和M2掺入bigels后,检查其抗氧化能力。获得的数据表明,BG-M1和BG-M2具有良好的品质,皮肤的自然pH值为(4.5-6.0),并且没有微生物发育的迹象。还进行了感官分析,未发现对令人讨厌的双耳特性的负面评价。 M1和M2对DPPH自由基具有抗氧化活性(数据表示为IC_(50)),M1为19×10〜(-3)mg / mL,M2为35×10〜(-3)mg / mL。配制后,对于BG-M1 = 3.0和BG-M2 = 1.1 mg / mL,他们保持了这一能力。同样,他们证明了有趣的ABTS清除对于M1和M2分别为1.5×10〜(-3)和2.5×10〜(-3)mg / mL。由于BG-M1 = 1.7 mg / mL和BG-M2 = 4.9 mg / mL,他们在配制后仍保持了这种潜力。同样,纯分子显示出显着的β-胡萝卜素漂白抑制作用(M1和M2分别为0.3和0.1 mg / mL),在将其配制成大分子后仍保持不变(BG-M1和BG-M2分别为2.9和10.3 mg / mL)。 。这些保持M1和M2的抗氧化潜能的二元酚可用作保护皮肤的屏障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号